Posted by Equitymaster The European markets were the biggest losers this week. Stock markets in Germany and France fell as much as 5.2% and 4.9%... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/ls5ppzSV6Zs/tm.asp
Deven Choksey of KRChoksey Investment Managers told CNBC-TV18, "From the clarification that one has got from different companies on the API front,... ...http://www.moneycontrol.com/news/stocks-views/positivelargecap-pharma-stocks-cement-deven-choksey_5323341.html
The leukemia medicine Gleevec that is manufactured by Novartis now has a competitor. A generic variant of the medicine has been introduced by Sun... ...http://www.topnews.in/sun-launches-gleevec-s-generic-variant-2406833
An explosion of copycat generics of the blockbuster cancer drug Gleevec is likely to result the Swiss pharma giant, Novartis, taking an impact of... ...http://m.hindustantimes.com/business/novartis-eyes-2-5-billion-hit-from-gleevec-copies/story-dzBE6F3hQ5kQykC3xNsikI.html
A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, India, August 24, 2015. Reuters/Danish... ...http://in.reuters.com/article/india-sensex-nifty-stock-markets-idINKCN0VC0OK
For Buying Imatinib & Gleevec Online...